✦ LIBER ✦
Using quality-adjusted progression-free survival as an outcome measure to assess the benefits of cancer drugs in randomized-controlled trials: case of the BOLERO-2 trial
✍ Scribed by Vakaramoko Diaby,Georges Adunlin,Askal Ayalew Ali…
- Book ID
- 126353405
- Publisher
- Springer US
- Year
- 2014
- Tongue
- English
- Weight
- 189 KB
- Volume
- 146
- Category
- Article
- ISSN
- 0167-6806
No coin nor oath required. For personal study only.